CVE-2022-45611

CRITICAL

9.8

Description

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Details CVE

Score CVSS v3.19.8

SeveriteCRITICAL

Vecteur CVSSCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Vecteur d'attaqueNETWORK

ComplexiteLOW

Privileges requisNONE

Interaction utilisateurNONE

Publie8/22/2023

Derniere modification11/21/2024

Sourcenvd

Observations honeypot0

Produits affectes

fresenius-kabi:pharmahelpfresenius-kabi:pharmahelp_firmware

Faiblesses (CWE)

CWE-522

References

https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder(cve@mitre.org)

https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf(cve@mitre.org)

https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf(cve@mitre.org)

https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder(af854a3a-2127-422b-91ae-364da2661108)

https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf(af854a3a-2127-422b-91ae-364da2661108)

https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf(af854a3a-2127-422b-91ae-364da2661108)

Correlations IOC

Aucune correlation enregistree

This product uses data from the NVD API but is not endorsed or certified by the NVD.